Genmab Share Price Nasdaq Copenhagen
Stocks
DK0010272202
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe Europe
08:30:45 02/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,257.00 DKK | +85.46% |
|
+4.14% | +14.24% |
| 29/09 | Nordic stocks in North America - Ericsson rose 1.7 percent | FW |
| 24/09 | AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma | MT |
| Market Cap | 13TCr 2.03TCr 1.81TCr 1.68TCr 1.54TCr 2.9TCr 1,95300Cr 2.92TCr 20TCr 7.9TCr 1LCr 7.63TCr 7.46TCr 3,20400Cr | P/E 2026 * |
28.8x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 15TCr 2.32TCr 2.06TCr 1.93TCr 1.75TCr 3.31TCr 2,23200Cr 3.34TCr 23TCr 9.03TCr 1,14100Cr 8.72TCr 8.53TCr 3,66200Cr | EV / Sales 2026 * |
5.3x | EV / Sales 2027 * | 4.32x |
| Free-Float |
94.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab
| 1 day | -0.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 58 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +85.46% | +4.14% | - | - | 2.08TCr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.44TCr | |
| -3.11% | -3.53% | +21.92% | +74.60% | 5.93TCr | |
| +0.89% | -0.63% | +4.28% | +34.51% | 4.71TCr | |
| -0.73% | -4.27% | +26.67% | +33.50% | 4.29TCr | |
| +0.40% | +0.46% | +350.57% | +686.82% | 4.41TCr | |
| -0.63% | -1.55% | +2.92% | +99.02% | 4.08TCr | |
| -0.54% | +2.93% | +9.50% | +50.41% | 3.08TCr | |
| -2.68% | +5.11% | +33.11% | +19.50% | 2.93TCr | |
| +2.52% | -5.77% | -27.34% | +337.64% | 2.37TCr | |
| Average | -0.01% | -0.64% | +52.33% | +158.91% | 4.36TCr | |
| Weighted average by Cap. | +0.21% | -0.40% | +57.39% | +150.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.91TCr 437.92Cr 389.09Cr 363.15Cr 331Cr 624.26Cr 42TCr 630.08Cr 4.39TCr 1.7TCr 22TCr 1.64TCr 1.61TCr 69TCr | 3.38TCr 508.58Cr 451.88Cr 421.75Cr 384.41Cr 725Cr 49TCr 731.75Cr 5.1TCr 1.98TCr 25TCr 1.91TCr 1.87TCr 80TCr |
| Net income | 498.25Cr 75Cr 67Cr 62Cr 57Cr 107Cr 7.22TCr 108Cr 753.29Cr 291.9Cr 3.69TCr 281.82Cr 275.7Cr 12TCr | 717.73Cr 108.12Cr 96Cr 90Cr 82Cr 154.14Cr 10TCr 155.57Cr 1.09TCr 420.48Cr 5.31TCr 405.96Cr 397.14Cr 17TCr |
| Net Debt | 1.93TCr 290.06Cr 257.72Cr 240.54Cr 219.24Cr 413.49Cr 28TCr 417.34Cr 2.91TCr 1.13TCr 14TCr 1.09TCr 1.07TCr 46TCr | 1.11TCr 167.13Cr 148.49Cr 138.59Cr 126.32Cr 238.25Cr 16TCr 240.46Cr 1.68TCr 649.93Cr 8.21TCr 627.48Cr 613.86Cr 26TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
